MedPath

Human intervention trial on the effect of long-term ingestion of dry powdered ecklonia stolonifera from Nishinoshima-chou on the reduction of nasal and eye discomfort

Not Applicable
Conditions
Healthy Adults
Registration Number
JPRN-UMIN000043543
Lead Sponsor
Healthcare Systems Co., Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1.Persons who have chronic illness, receiving medication, have a serious disease history (diabetes, liver disease, kidney disease, heart disease, respiratory disease, endocrine disease, etc.) 2.Persons who have allergy to the test food (ecklonia stolonifera), shrimp and crab. 3.Persons who regularly take test food (ecklonia stolonifera). 4.Persons who regularly take seaweed, foods containing seaweed or supplements. 5.Persons who are seeing or planning to see an otorhinolaryngologist. 6.Persons who have been diagnosed with acute rhinitis, sinusitis, or hypertrophic rhinitis. 7.Persons who have been diagnosed with bronchial asthma. 8.Persons who have severe anemia, alcoholism, or other mental disorders. 9.Persons who have a smoking habit. 10.Persons who regularly use medicines, specified health foods, or health foods that may affect nasal or eye discomfort. 11.Persons who may change their lifestyle during the study period (e.g., working at night, traveling for long periods of time). 12.Persons who plan to take new health foods or supplements during the study period. 13.Persons who have participated in other studies during the month prior to the start of the study, or persons who plan to participate in other studies after consenting to this study. 14.Persons who have been judged ineligible by the study supervising physician or principal investigator. 15.Persons who are breast-feeding, pregnant, or who plan or wish to become pregnant during the study period.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
QOL Questionnaire (Using the japan rhinoconjunctivitis quality of life questionnaire, JACQLQ ver.1)
Secondary Outcome Measures
NameTimeMethod
Evaluation of subjective nasal and eye symptoms (by recording in daily diary) Blood tests (6 specific IgE items, non-specific IgE, CRP) s-IgA in saliva (concentration, secretion rate)
© Copyright 2025. All Rights Reserved by MedPath